Skip to content
Clinical Trials – home

Endocarditis Diagnostics

2 / 2 trials open to patients2 countries

In short

Diagnosing endocarditis requires a careful combination of clinical observation, laboratory tests, and imaging studies to detect this potentially life-threatening infection of the heart's inner lining and valves. Because symptoms can develop slowly over weeks or suddenly within days, knowing when to seek medical attention and what tests are used can make a crucial difference in treatment outcomes.

Key points

  • Blood cultures must be drawn before starting antibiotics to identify the specific bacteria causing endocarditis and guide treatment choices
  • Transesophageal echocardiograms provide much clearer images of heart valves than standard chest echocardiograms and are often essential for detecting vegetations
  • The Duke criteria combine multiple findings—including blood cultures, imaging results, and clinical signs—to classify endocarditis as definite, possible, or rejected
  • People with artificial heart valves, damaged valves, or previous endocarditis should seek immediate medical attention for unexplained fevers or flu-like symptoms
  • Diagnosis typically takes several days, but treatment often begins immediately based on clinical suspicion before all test results are available
  • With early diagnosis and proper treatment, the survival rate for endocarditis is approximately 70-85%, though outcomes depend on multiple factors
  • Clinical trials for endocarditis use stricter diagnostic criteria and may require advanced imaging or molecular testing beyond standard clinical practice
  • Regular follow-up after treatment is crucial because patients who've had endocarditis once face higher risk of recurrence and need ongoing monitoring

Introduction: Who Should Undergo Diagnostics

Endocarditis should be suspected in anyone experiencing unexplained fevers, particularly when combined with other concerning symptoms. This is especially important if you have certain risk factors that make you more vulnerable to developing this infection. The disease affects the endocardium, which is the inner lining of the heart's chambers and valves, and can be fatal if not treated promptly.

You should seek medical attention as soon as possible if you experience symptoms like persistent fever, chills, night sweats, or fatigue, especially if you fall into a higher-risk group. People with artificial heart valves, damaged heart valves, or other heart defects need to be particularly vigilant, as damaged heart tissue makes it easier for bacteria to attach and grow. Those with a history of previous endocarditis, individuals who inject drugs, people with pacemakers or implantable cardioverter-defibrillators, and those on hemodialysis are also at elevated risk.

It's important to understand that endocarditis is not a common condition, affecting only about five to seven cases per 100,000 people each year. However, its rarity should not lead to complacency. The infection can progress rapidly, and early diagnosis is vital. If you have undergone recent invasive medical or dental procedures and develop fever or flu-like symptoms, this warrants immediate medical evaluation, as bacteria can enter the bloodstream during such procedures.

The symptoms of endocarditis can be quite variable and may resemble flu symptoms initially, which is why many people delay seeking care. Common signs include fever above 100°F (38.4°C), chills, fatigue, muscle and joint aches, and shortness of breath. Some people also experience chest pain when breathing, swelling in the feet or legs, or unexplained weight loss. Less common but distinctive signs include small spots on the skin, unusual lines under the fingernails, or blood in the urine.

People with certain heart conditions don't necessarily have a higher risk of endocarditis. For instance, if you've had bypass surgery, a heart attack without complications, or if you have mitral valve prolapse without other issues, your risk is not substantially increased. However, if you have heart valve disease, congenital heart defects, hypertrophic cardiomyopathy (where the heart muscle cells have enlarged), or have had a heart valve replaced or repaired, you should be more alert to potential symptoms.

Diagnostic Methods

When you visit your healthcare provider with suspected endocarditis, the diagnostic process begins with a thorough physical examination and discussion of your medical history. Your doctor will listen carefully to your symptoms and ask about any recent procedures, dental work, or infections you may have had. During the physical exam, they will check for signs of infection such as fever, listen to your heart for abnormal sounds called heart murmurs, and examine your skin and nails for unusual spots or marks that can indicate endocarditis.

The cornerstone of endocarditis diagnosis is blood culture testing. This test is crucial because it helps identify the specific germs causing the infection in your bloodstream. Your doctor will typically draw multiple blood samples from different sites at different times, usually at least two or three separate cultures. This repetition is important because it increases the likelihood of catching the bacteria in your blood and helps rule out contamination. The blood samples are sent to a laboratory where they are placed in special conditions that encourage bacteria or fungi to grow, making them easier to identify.

It's critical that these blood cultures are taken before you start taking antibiotics. Starting antibiotics too early can make it much harder to identify the organism causing the infection, which in turn makes it difficult to choose the most effective treatment. The results from blood cultures also help determine which specific antibiotics will work best against your particular infection, as different bacteria respond to different medications.

Blood tests beyond cultures are also performed. A complete blood count can reveal whether you have elevated white blood cells, which indicates infection, or if you have anemia (low red blood cells), which can be a sign of endocarditis. These tests provide supporting evidence but cannot definitively diagnose the condition on their own.

Imaging tests play a vital role in diagnosing endocarditis. The most important imaging test is an echocardiogram, which uses sound waves to create moving pictures of your heart. This test shows how well your heart chambers and valves are working and can reveal the structure of your heart. There are two main types of echocardiograms used in diagnosing endocarditis. The first is a transthoracic echocardiogram, which is performed by moving a device over your chest. This is the standard, non-invasive version of the test.

When more detailed images are needed, your doctor may recommend a transesophageal echocardiogram. In this procedure, a flexible tube with a tiny ultrasound device is gently guided down your throat and into your esophagus (the tube connecting your mouth to your stomach). Because the esophagus sits right behind the heart, this test can provide much clearer and more detailed pictures of your heart valves and any abnormalities, such as vegetations (clumps of bacteria, fibrin, and blood cells) that form on infected heart tissue.

An electrocardiogram (ECG or EKG) is another test commonly performed. This quick and painless procedure measures the electrical activity of your heart using sensors attached to your chest and sometimes your arms or legs. While an ECG isn't specifically used to diagnose endocarditis itself, it can detect if the infection is affecting your heart's electrical system or causing irregular heartbeats, which is important information for your treatment plan.

Chest X-rays may also be ordered to check the size of your heart and look for signs of complications. A chest X-ray can show if your heart is enlarged or if fluid has built up in your lungs, which might indicate that endocarditis is affecting your heart's ability to pump blood effectively. This helps your healthcare team understand the severity of your condition.

In some cases, additional imaging tests such as MRI (magnetic resonance imaging) or CT (computed tomography) scans may be needed. These tests provide even more detailed images and can help identify complications such as abscesses (pockets of infection) in the heart muscle or blood clots that may have formed and traveled to other parts of your body.

Urine tests may be performed to check for blood in the urine, which can occur when small pieces of infected material break off from the heart and travel to the kidneys. This finding, along with other test results, helps paint a complete picture of how the infection is affecting your body.

The diagnosis of endocarditis typically relies on a set of criteria called the Duke criteria, which combine clinical findings, laboratory results, and imaging findings. These criteria classify endocarditis cases as "definite," "possible," or "rejected" based on the presence of major and minor criteria. Major criteria include positive blood cultures showing typical bacteria that cause endocarditis, or evidence of heart involvement seen on echocardiography. Minor criteria include fever, certain risk factors (like heart valve disease or intravenous drug use), blood vessel and immune system phenomena, and other supportive laboratory findings.

The diagnostic process may take several days because blood cultures need time to grow in the laboratory, and multiple tests need to be coordinated. However, treatment often begins before all test results are complete, especially if your symptoms suggest a serious infection. Your doctor may start you on broad-spectrum antibiotics that work against many different types of bacteria, and then adjust your treatment once the specific organism is identified.

Diagnostics for Clinical Trial Qualification

When patients with endocarditis are being considered for enrollment in clinical trials, the diagnostic requirements may be more rigorous and standardized than in routine clinical practice. Clinical trials testing new treatments for endocarditis need to ensure that all participants truly have the condition and that it's accurately characterized, so they use specific criteria to qualify patients.

For clinical trial enrollment, confirmed diagnosis using the Duke criteria is typically required. This means patients must meet either two major criteria, one major and three minor criteria, or five minor criteria to be classified as having "definite endocarditis." The Duke criteria have been updated over time, most recently in 2023, to incorporate newer diagnostic techniques such as advanced imaging methods and molecular testing approaches that weren't available when the original criteria were developed.

Blood culture results are particularly important for clinical trial qualification. Trials usually require documentation of positive blood cultures with specific organisms known to cause endocarditis, such as Staphylococcus aureus, viridans streptococci, enterococci, or other bacteria commonly associated with the condition. Multiple positive blood cultures drawn at different times strengthen the case for enrollment. Some trials may also use newer microbiological techniques such as enzyme immunoassays or molecular methods like PCR (polymerase chain reaction) to detect organisms that are difficult to grow in standard blood cultures.

Imaging studies, particularly echocardiography, must demonstrate specific findings for clinical trial eligibility. The transesophageal echocardiogram is often preferred because it provides more detailed images and is better at detecting vegetations, abscesses, or valve damage. Trial protocols typically specify the size and characteristics of vegetations that qualify a patient for inclusion. Some newer trials may also incorporate advanced imaging techniques such as cardiac computed tomography or PET scans (positron emission tomography), which can detect inflammation and infection in heart tissue with high precision.

Additional laboratory tests may be required for clinical trial screening beyond what's done in routine care. These might include specific inflammatory markers in the blood, kidney function tests, liver function tests, and tests to assess your overall health status. Trials need to ensure that participants are healthy enough to safely receive the experimental treatment and can tolerate the study procedures.

Some clinical trials may have specific inclusion criteria related to the type of endocarditis. For example, a study might focus only on patients with native valve endocarditis (infection of the patient's own heart valve) or only on those with prosthetic valve endocarditis (infection of an artificial replacement valve). The timing of diagnosis may also matter—some trials only accept patients in the early stages of infection, while others may study patients with more advanced disease or those who have failed initial treatment.

Documentation of any complications from endocarditis is also important for trial qualification. This includes evidence of heart failure, embolic events (where pieces of vegetation break off and travel to other organs), abscesses, or the need for surgery. Trials studying different aspects of endocarditis management may specifically seek patients with or without certain complications.

Before enrolling in a clinical trial, you would typically undergo a comprehensive baseline assessment. This serves both to confirm your eligibility and to establish a starting point against which your response to treatment can be measured. This assessment usually includes detailed blood work, multiple imaging studies, and sometimes additional specialized tests depending on the specific trial protocol.

Prognosis and Survival Rate

Prognosis

The outlook for patients with endocarditis depends on several important factors. With quick and aggressive treatment, many people survive endocarditis, but without treatment, the condition can be fatal. The prognosis varies based on the type of infection, which organism is causing it, how quickly treatment begins, and whether complications develop.

Several factors can affect your chances of recovery. Patients who receive early diagnosis and appropriate antibiotic treatment generally have better outcomes. The type of bacteria causing the infection matters significantly—infections caused by Staphylococcus aureus tend to be more aggressive and have a poorer prognosis than those caused by streptococcal bacteria. Whether the infection affects a native heart valve or a prosthetic valve also influences outcomes, as prosthetic valve infections are typically more difficult to treat.

Age and overall health status play important roles in prognosis. Older adults and people with weakened immune systems or multiple medical conditions may face more challenges during treatment. The development of complications such as heart failure, stroke, abscesses, or the need for emergency heart surgery also affects the prognosis. Some patients require ongoing monitoring for months or even years after treatment to ensure the infection doesn't return and to check heart function.

Patients who have had endocarditis once are at higher risk of developing it again in the future. This is why following preventive measures, maintaining good dental hygiene, and taking prophylactic antibiotics before certain procedures (when recommended by your doctor) are so important for long-term health. Regular follow-up visits with your healthcare provider help monitor your heart's condition and catch any problems early.

Survival rate

Endocarditis carries significant mortality risk, with survival rates depending on multiple factors. Studies indicate that the estimated inpatient mortality rate for endocarditis ranges between 15% and 30%. This means that among patients hospitalized with endocarditis, approximately 70% to 85% survive their hospital stay with appropriate treatment.

The mortality rate can vary based on specific circumstances. Acute endocarditis, which develops suddenly with severe symptoms, tends to have higher mortality than subacute endocarditis, which develops more gradually over weeks or months. Patients who develop serious complications such as heart failure, stroke, or sepsis face higher risks than those whose infection is caught and treated early without complications.

It's important to note that these statistics represent averages across large groups of patients and may not reflect your individual situation. Your personal prognosis depends on your specific circumstances, including the organism causing your infection, how quickly you receive treatment, your overall health, and how your body responds to antibiotics. Many people recover completely from endocarditis with proper treatment and go on to live normal, healthy lives.

Did you know?

  1. The vegetations that form in endocarditis are made up of bacteria or fungi trapped in a matrix of fibrin (a blood clotting protein) and platelets, creating a protective shield that makes antibiotics less effective and requires prolonged treatment lasting several weeks.[2]
  2. Non-infective endocarditis exists as a rare form where sterile vegetations form on heart valves without any infection, often linked to conditions like lupus or cancer, and people may not even know they have it until imaging is done for other reasons.[2][11]
  3. Advances in medical care have paradoxically increased endocarditis rates because more people now have artificial heart valves, pacemakers, and other implanted cardiac devices that bacteria can colonize, changing the face of this ancient disease.[3]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Endocarditis

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:UZ Leuven
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin
  • Sponsor:Region Skane
See all 2 trials →filters applied: condition = Endocarditis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).